Medical and Pharmaceutical Markets: Facing the Challenge of Ageing Societies in Japan and Europe
Japan is facing a deep change in its demographic structure; an ageing population and a low birth rate will force authorities to rethink domestic welfare and healthcare systems, to ensure their sustainability. The Japanese government is taking measures to increase the country’s birth rate, to reform the pension system and medical and nursing care insurance, and exploring the opportunity of a technological upgrade of its healthcare and pharmaceutical sectors, targeted to age-related diseases. Moreover, there are ongoing negotiations with Europe for a free-trade agreement that would also have a significant impact on these sectors, which have traditionally been heavily protected and regulated on both sides. This roundtable will explore these intertwined issues and will seek to identify policy measures to enhance the sustainability and competitiveness of the welfare system.
This event is supported by the Japan External Trade Organization, Daiwa Capital Markets, Daiwa Anglo-Japanese Foundation, AstraZeneca, Hitachi and the Development Bank of Japan, and organized with the help of The Japan Society.